Your browser doesn't support javascript.
loading
Risk factors for cardiovascular adverse events from immune checkpoint inhibitors.
Luo, Lingli; Liu, Yuxin; Lu, Jingfen; Zhang, Yifei; Fan, Gang; Tang, Xiaojun; Guo, Weiming.
Affiliation
  • Luo L; Medical College, Hunan Polytechnic of Environment and Biology, Hengyang, China.
  • Liu Y; College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.
  • Lu J; The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhang Y; The First Teaching Hospital, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Fan G; Urology Department, Huazhong University of Science and Technology Union Shenzhen Hospital, the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China.
  • Tang X; Department of Spinal Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • Guo W; Sports Medicine Department, Huazhong University of Science and Technology Union Shenzhen Hospital, the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China.
Front Oncol ; 13: 1104888, 2023.
Article in En | MEDLINE | ID: mdl-37188194
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland